PTH and Hypocalcemia: Patients with end stage renal disease under dialysis (hemodialysis or peritoneal dialysis) have low levels of 1,25 (OH) 2 D3, which results in a decrease in calcium absorption which leads to hypocalcemia and a secondary increase in PTH secretion.